Dispozitive medicale și consumabile pentru Laboratorul Imunologic
Information about customer
Title
IMSP Institutul Oncologic
IDNO
1003600151023
Address
MOLDOVA,
locality,
str. Testemitanu, 30,
MD 2025
The contact person
Jora Vitalie,
vitaliejora@mail.ru
Purchase data
ID
ocds-b3wdp1-MD-1651063050766
Title
Dispozitive medicale și consumabile pentru Laboratorul Imunologic
Note
CPV Code
33100000-1 - Echipamente medicale
Rationale
List of funding sources
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1651063051693
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1651063715711
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1653301927856
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1653301927702
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1654762546262
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1654762546065
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1654762545534
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1654762546426
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1654762545688
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1654762545881
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1656920113031
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1656920112872
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1656920113202
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1656920113566
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1656920113383
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1656920113771
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1659334501301
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1659334501577
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1659334501823
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1659334501977
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1659334501390
IBAN
None
Funding source cost
144630.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1651063050766-FS-1659334502163
IBAN
None
Status Planning
Start the procedure:
1 Jan 2022
1 Jan 2023
Date of publication: 27 Apr 2022 15:40
Date of last modifications: 1 Aug 2022 09:15